Table 3.
The cost differences for patients in the experimental group and the comparison group
| Cost Variable |
Experimental Group (C-AKIC) n = 138 |
Comparison Group (Current State) n = 136 |
p Value* | 95% Confidence Interval | Cost Ratio** | ||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||||
| Patient |
647.51 |
1825.54 |
1855.64 |
4615.32 |
<0.005 |
375.54 -2040.73 |
0.35 |
| Provincial healthcare |
1205.32 |
1757.52 |
3595.02 |
2042.31 |
<0.001 |
1934.82 -2844.57 |
0.34 |
| Insurance |
687.24 |
795.17 |
1503.67 |
1247.79 |
<0.001 |
566.64 -1066.22 |
0.46 |
| MRI |
109.32 |
215.50 |
331.88 |
288.59 |
<0.001 |
161.75 -283.36 |
0.33 |
| Total | 2549.59 | 3172.73 | 6954.33 | 5953.35 | <0.001 | 3265.86 -5543.62 | 0.37 |
*t-test for independent samples.
**Cost ratio = ratio of costs for experimental group to costs for comparison group.